Company: MIRM
Filing Date: 2025-12-19
Form Type: 8-K
Source: 0001193125-25-325825
Chunk: 2

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-12-19
Form: 8-K
Item: Item 3.02
Chunk 2
---
Item 3.02      Unregistered Sales of Equity Securities.  

To the extent required by Form8-K, the disclosures in Item 1.01 of this Form8-Kare incorporated into this Item 3.02 by reference.

Based in part upon the representations of the PIPE Investors in the Subscription Agreement, the offering and sale of the securities in the Private Placement will be made in reliance on the exemptions afforded by Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act, and corresponding provisions of applicable state securities or “blue sky” laws. The PIPE Investors represented that they are accredited investors, as such term is defined in Rule 501(a) of Regulation D under the Securities Act, and that they are acquiring the securities for investment purposes only and not with a view to any resale, distribution or other disposition of the securities in violation of the U. S. federal securities laws.

The securities to be issued in the Private Placement will not be registered under the Securities Act or any state securities laws upon issuance and may not be offered or sold in the United States absent registration under the Securities Act or an applicable exemption from the registration requirements. The sale of the securities in the Private Placement did not involve a public offering and will be made without general solicitation or general advertising.

Neither this Form 8-K nor anyexhibit attached hereto is an offer to sell or the solicitation of an offer to buy shares of Common Stock or other securities of the Company.

  Item 7.01      Regulation FD Disclosure.  

On December 19, 2025, the Company issued a press release announcing its entry into the Subscription Agreement, a copy of which is furnished as Exhibit 99.1 to this Form8-K.

As provided in General Instruction B.2 of Form8-K, the information in this Item 7.01, including Exhibit 99.1 hereto, shall not be deemed to be “filed” for purposes of, or otherwise subject to the liabilities under, Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.

Forward-Looking Statements

This Form8-Kcontains “forward-looking statements” within the meaning of Section